Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells
暂无分享,去创建一个
Mehmet Toner | Elena Brachtel | David N Louis | Anya Kimura | Min Yu | Shannon L Stott | Aditya Bardia | Ravi Kapur | Jordan C. Ciciliano | D. Louis | D. Haber | L. Sequist | Xi Luo | A. Bardia | E. Ozkumur | M. Toner | N. M. Karabacak | P. Spuhler | Kyle Smith | Pin-i Chen | B. Morgan | Julie Trautwein | T. Barber | S. Stott | S. Maheswaran | R. Kapur | A. Shaw | D. Ting | Ajay M. Shah | D. T. Miyamoto | Jordan C Ciciliano | Richard J Lee | Min Yu | E. Brachtel | Shyamala Maheswaran | James P. Sullivan | Daniel A Haber | Lecia V Sequist | Xi Luo | David T Ting | Alice T Shaw | David T Miyamoto | Emre Ozkumur | James P Sullivan | Nezihi Murat Karabacak | B. Emmink | Anya M. Kimura | Sudarshana Sengupta | John R Walsh | Julie Trautwein | Shannon L. Stott | Ajay M Shah | Benjamin L Emmink | Pin-i Chen | Bailey Morgan | Sudarshana Sengupta | Thomas A Barber | Kyle Smith | Philipp S Spuhler | Kyle C. Smith | S. Sengupta | J. Sullivan | John R. Walsh | D. Miyamoto
[1] Mehmet Toner,et al. Circulating tumor cells: approaches to isolation and characterization , 2011, The Journal of cell biology.
[2] J. Chalmers,et al. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells , 2009, Biotechnology and bioengineering.
[3] Andreas Radbruch,et al. High gradient magnetic cell separation with MACS. , 1990, Cytometry.
[4] G. Doyle,et al. Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer , 2009, Journal of oncology.
[5] S. Digumarthy,et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology , 2007, Nature.
[6] J. Sturm,et al. Continuous Particle Separation Through Deterministic Lateral Displacement , 2004, Science.
[7] Sridhar Ramaswamy,et al. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. , 2012, Cancer discovery.
[8] R. Tompkins,et al. A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women , 2008, Prenatal diagnosis.
[9] G. Segré,et al. Radial Particle Displacements in Poiseuille Flow of Suspensions , 1961, Nature.
[10] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[11] Cesar M. Castro,et al. Ultrasensitive Clinical Enumeration of Rare Cells ex Vivo Using a Micro-Hall Detector , 2012, Science Translational Medicine.
[12] Maciej Zborowski,et al. Enrichment of rare cancer cells through depletion of normal cells using density and flow-through, immunomagnetic cell separation. , 2004, Experimental hematology.
[13] Peter Kuhn,et al. A rare-cell detector for cancer. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] Mark M Davis,et al. Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device , 2009, Proceedings of the National Academy of Sciences.
[15] Mehmet Toner,et al. Isolation and Characterization of Circulating Tumor Cells from Patients with Localized and Metastatic Prostate Cancer , 2010, Science Translational Medicine.
[16] Mieke Schutte,et al. Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells , 2009, Journal of the National Cancer Institute.
[17] Mehmet Toner,et al. Detection of mutations in EGFR in circulating lung-cancer cells. , 2008, The New England journal of medicine.
[18] D. Krag,et al. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients , 2008, Breast Cancer Research.
[19] Raghu Kalluri,et al. The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.
[20] Shashi K Murthy,et al. Computational design optimization for microfluidic magnetophoresis. , 2011, Biomicrofluidics.
[21] J. Baselga,et al. The Evolving War on Cancer , 2011, Cell.
[22] K. Isselbacher,et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip , 2010, Proceedings of the National Academy of Sciences.
[23] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[24] Francis Barany,et al. High-throughput selection, enumeration, electrokinetic manipulation, and molecular profiling of low-abundance circulating tumor cells using a microfluidic system. , 2011, Analytical chemistry.
[25] Sridhar Ramaswamy,et al. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. , 2009, Genes & development.
[26] David J. Beebe,et al. Circulating Tumor Cells: Getting More from Less , 2012, Science Translational Medicine.
[27] Joshua M. Kunken,et al. Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers , 2012, Physical biology.
[28] Aaron J Mackey,et al. Getting More from Less , 2002, Molecular & Cellular Proteomics.
[29] R. Tompkins,et al. Continuous inertial focusing, ordering, and separation of particles in microchannels , 2007, Proceedings of the National Academy of Sciences.
[30] Yi-Kuen Lee,et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. , 2011, Angewandte Chemie.
[31] Ruud H. Brakenhoff,et al. Detection, clinical relevance and specific biological properties of disseminating tumour cells , 2008, Nature Reviews Cancer.